{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:42:31Z","timestamp":1782877351155,"version":"3.54.5"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jep.2017.03.026","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T15:19:25Z","timestamp":1489850365000},"page":"184-191","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Biochemical and chemical characterization of Cynara cardunculus L. extract and its potential use as co-adjuvant therapy of chronic myeloid leukemia"],"prefix":"10.1016","volume":"202","author":[{"given":"Antonio","family":"Russo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariarita","family":"Perri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Cione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Di Gioia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cristina Caroleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2017.03.026_bib1","doi-asserted-by":"crossref","first-page":"8376","DOI":"10.1021\/jacs.6b04330","article-title":"Synthesis of a potent vinblastine: rationally designed added benign complexity","volume":"138","author":"Allemann","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jep.2017.03.026_bib2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific p210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.jep.2017.03.026_bib3","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.beha.2016.10.017","article-title":"Beyond tyrosine kinase inhibitors: combinations and other agents","volume":"29","author":"Cayssials","year":"2016","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"22","key":"10.1016\/j.jep.2017.03.026_bib4","doi-asserted-by":"crossref","first-page":"10959","DOI":"10.1158\/0008-5472.CAN-06-1216","article-title":"A sequential blockade strategy for the design of combination therapies to overcome oncogene addiction in chronic myelogenous leukemia","volume":"66","author":"Chen","year":"2006","journal-title":"Cancer Res."},{"issue":"2\u20133","key":"10.1016\/j.jep.2017.03.026_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2004.03.027","article-title":"Cytotoxic and pro-apoptotic activities of cynaropicrin, a sesquiterpene lactone, on the viability of leukocyte cancer cell lines","volume":"492","author":"Cho","year":"2004","journal-title":"Eur. J. Pharm."},{"issue":"1","key":"10.1016\/j.jep.2017.03.026_bib6","first-page":"3","article-title":"Influence of all-trans-retinoic acid on oxoglutarate carrier via retinoylation reaction","volume":"1791","author":"Cione","year":"2009","journal-title":"Biochem. Biophys. Acta"},{"key":"10.1016\/j.jep.2017.03.026_bib7","doi-asserted-by":"crossref","unstructured":"Daley, G.Q., Baltimore, D., 1988. Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific p210 bcr\/abl protein. Proceedings Natl. Acad. Sci. USA. 5, 9312\u20139316.","DOI":"10.1073\/pnas.85.23.9312"},{"key":"10.1016\/j.jep.2017.03.026_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1126\/science.2406902","article-title":"Induction of chronic myelogenous leukemia in mice by the p210bcr\/abl gene of the Philadelphia chromosome","volume":"247","author":"Daley","year":"1990","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.jep.2017.03.026_bib9","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jep.2017.03.026_bib10","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jnatprod.6b00285","article-title":"Natural-based indirubins display potent cytotoxicity toward wild-type and T315I-resistant leukemia cell lines","author":"Gaboriaud-Kolar","year":"2016","journal-title":"J. Nat. Prod."},{"issue":"9","key":"10.1016\/j.jep.2017.03.026_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/nure.12051","article-title":"Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives","volume":"71","author":"Gonz\u00e1lez-Vallinas","year":"2013","journal-title":"Nutr. Rev."},{"issue":"3","key":"10.1016\/j.jep.2017.03.026_bib12","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1158\/0008-5472.CAN-06-2014","article-title":"Growth factor stimulation reduces residual quiescent chronic myelogenous leukemia progenitors remaining after imatinib treatment","volume":"67","author":"Holtz","year":"2007","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.jep.2017.03.026_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23691","article-title":"Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management","volume":"89","author":"Jabbour","year":"2014","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.jep.2017.03.026_bib14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.7326\/0003-4819-145-12-200612190-00008","article-title":"New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance","volume":"145","author":"Kantarjian","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.jep.2017.03.026_bib15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ijc.2910180405","article-title":"Properties of the K562 cell line, derived from a patient with chronic myeloid leukemia","volume":"18","author":"Klein","year":"1976","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jep.2017.03.026_bib16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4236\/pp.2013.43A003","article-title":"The success of natural products in drug discovery","volume":"4","author":"Lahlou","year":"2013","journal-title":"Pharmacol. Pharm."},{"key":"10.1016\/j.jep.2017.03.026_bib17","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.biocel.2007.01.027","article-title":"Src kinase signaling in leukaemia","volume":"39","author":"Li","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jep.2017.03.026_bib18","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/sj.leu.2403950","article-title":"Dual tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"19","author":"Martinelli","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.jep.2017.03.026_bib19","doi-asserted-by":"crossref","unstructured":"McLaughlin, J., Chianese, E., Witte, O.N., 1987. In vitro transformation of immature hematopoietic cells by the p210 BCR\/ABL oncogene product of the Philadelphia chromosome. Proceedings Natl. Acad. Sci. USA, 84, 6558\u20136562.","DOI":"10.1073\/pnas.84.18.6558"},{"issue":"2","key":"10.1016\/j.jep.2017.03.026_bib20","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2165\/00003495-200767020-00010","article-title":"Imatinib: a review of its use in chronic myeloid leukaemia","volume":"67","author":"Moen","year":"2007","journal-title":"Drugs"},{"issue":"22","key":"10.1016\/j.jep.2017.03.026_bib21","first-page":"7950","article-title":"Arsenic trioxide inhibits translation of mRNA of bcr-abl, resulting in attenuation of Bcr-Abl levels and apoptosis of human leukemia cells","volume":"63","author":"Nimmanapalli","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.jep.2017.03.026_bib22","first-page":"1497","article-title":"A minute chromosome in human chronic granulocytic leukemia","volume":"132","author":"Nowell","year":"1960","journal-title":"Science"},{"key":"10.1016\/j.jep.2017.03.026_bib23","doi-asserted-by":"crossref","first-page":"4500","DOI":"10.1158\/0008-5472.CAN-05-0259","article-title":"In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants","volume":"65","author":"O\u2019Hare","year":"2005","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.jep.2017.03.026_bib24","article-title":"Basic condition to formazan improves sensitivity of the MTT colorimetric assay dye","volume":"1","author":"Perri","year":"2016","journal-title":"J. Bioanal. Tech."},{"key":"10.1016\/j.jep.2017.03.026_bib25","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1023\/B:GRES.0000024786.01004.71","article-title":"Wild artichokes of south Italy: did the story begin here?","volume":"51","author":"Pignone","year":"2004","journal-title":"Genet. Res. Crop Evol."},{"issue":"35","key":"10.1016\/j.jep.2017.03.026_bib26","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1021\/jf402253a","article-title":"Lipophilic extracts of Cynara cardunculus L. var. altilis (DC): a source of valuable bioactive terpenic compounds","volume":"61","author":"Ramos","year":"2013","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.jep.2017.03.026_bib27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.jep.2017.03.026_bib28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1046\/j.1365-2141.1997.d01-1982.x","article-title":"Clinical features at diagnosis in 430 patients with chronic myeloid leukemia seen at a referral center over a 16-year period","volume":"96","author":"Savage","year":"1997","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.jep.2017.03.026_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1126\/science.1099480","article-title":"Overriding imatinib resistance with a novel ABL kinase inhibitor","volume":"305","author":"Shah","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.jep.2017.03.026_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0308-2261(21)00550-6","article-title":"The clinical features of chronic granulocytic leukemia","volume":"6","author":"Spiers","year":"1977","journal-title":"Clin. Hematol."},{"key":"10.1016\/j.jep.2017.03.026_bib31","first-page":"596483","article-title":"Therapy of chronic myeloid leukemia: twilight of the imatinib era?","volume":"2014","author":"Trela","year":"2014","journal-title":"ISRN Oncol."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874117302696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874117302696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T13:05:14Z","timestamp":1658840714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874117302696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"alternative-id":["S0378874117302696"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2017.03.026","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biochemical and chemical characterization of Cynara cardunculus L. extract and its potential use as co-adjuvant therapy of chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2017.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}